Kolexia
Lucidarme Damien Gastro-entérologie
Lucidarme Damien
Gastro-entérologie
Groupement des Hôpitaux de l'Institut Catholique de Lille
Lille, France
50 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Hépatite chronique Hépatite C chronique Cirrhose du foie Kyste du pancréas Kystes Fibrose Tumeurs du pancréas

Collaborateurs

Voir plus
Canva-Delcambre Valérie
Canva-Delcambre Valérie
Hôpital Huriez, Lille, France
Napoleon Bertrand
Napoleon Bertrand
Polyclinique Lyon Nord, Rillieux-la-Pape, France
Lucidarme Camille
Lucidarme Camille
Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France
Duburque Clotilde
Duburque Clotilde
Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France

Industries

Voir plus
A+A
16 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
6 collaboration(s)
Dernière en 2023
Abbvie
5 collaboration(s)
Dernière en 2023
Mayoly Spindler
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients.
European journal of gastroenterology & hepatology   05 octobre 2020
CONTACT: Clinical Evaluation Of NCLE in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas
Essai Clinique (Mauna Kea Technologies)   28 août 2017
Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
The American journal of gastroenterology   15 août 2017
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study.
Infectious diseases and therapy   05 mai 2017
INTEGRATE: Observational Multicenter Study in Ex-People Who INject Drugs (Ex-PWIDs) to Evaluate Efficacy, Safety, and Adherence to TElaprevir in Combination With Pegylated Interferon Alfa and Ribavirin in Genotype 1 ChRonic HepATitis C PatiEnts
Essai Clinique (Janssen)   01 mars 2017
CUPIC: Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) Included in the French Early Access Program for the Use of Protease Inhibitors in Genotype 1 Patients Who Failed to Eradicate HCV With a Previous Standard PEG-IFN and RBV Combination.
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   23 janvier 2017
Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy in solid pancreatic masses.
Endoscopy   30 août 2016
A 3 year follow-up of HCV infection in opioid use disorder patients in treatment
Drug and alcohol dependence   01 novembre 2015
Simeprevir plus sofosbuvir for the treatment of hepatitis C genotype 1 and 4 in a French multicenter cohort in real life: ReaL-SimSof study
The 66th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2015   07 octobre 2015
In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluation.
Surgical endoscopy   01 octobre 2015